- Home
- EEIQ vs NERV Comparison
EEIQ vs NERV Comparison
Compare EEIQ & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EEIQ
- NERV
- Stock Information
- Founded
- EEIQ 2017
- NERV 2007
- Country
- EEIQ United States
- NERV United States
- Employees
- EEIQ N/A
- NERV N/A
- Industry
- EEIQ Other Consumer Services
- NERV Biotechnology: Pharmaceutical Preparations
- Sector
- EEIQ Real Estate
- NERV Health Care
- Exchange
- EEIQ Nasdaq
- NERV Nasdaq
- Market Cap
- EEIQ 10.7M
- NERV 10.7M
- IPO Year
- EEIQ 2021
- NERV 2014
- Fundamental
- Price
- EEIQ $0.72
- NERV $1.62
- Analyst Decision
- EEIQ
- NERV Hold
- Analyst Count
- EEIQ 0
- NERV 1
- Target Price
- EEIQ N/A
- NERV $5.00
- AVG Volume (30 Days)
- EEIQ 37.1K
- NERV 31.3K
- Earning Date
- EEIQ 03-25-2025
- NERV 04-30-2025
- Dividend Yield
- EEIQ N/A
- NERV N/A
- EPS Growth
- EEIQ N/A
- NERV N/A
- EPS
- EEIQ N/A
- NERV 0.19
- Revenue
- EEIQ $8,153,546.00
- NERV N/A
- Revenue This Year
- EEIQ N/A
- NERV N/A
- Revenue Next Year
- EEIQ N/A
- NERV N/A
- P/E Ratio
- EEIQ N/A
- NERV $8.84
- Revenue Growth
- EEIQ 42.73
- NERV N/A
- 52 Week Low
- EEIQ $0.60
- NERV $1.42
- 52 Week High
- EEIQ $1.22
- NERV $3.69
- Technical
- Relative Strength Index (RSI)
- EEIQ 34.06
- NERV 38.16
- Support Level
- EEIQ $0.76
- NERV $1.53
- Resistance Level
- EEIQ $0.86
- NERV $1.74
- Average True Range (ATR)
- EEIQ 0.09
- NERV 0.16
- MACD
- EEIQ -0.01
- NERV 0.01
- Stochastic Oscillator
- EEIQ 2.32
- NERV 36.43
About EEIQ EpicQuest Education Group International Limited
EpicQuest Education Group International Ltd provides comprehensive education solutions for domestic and international students interested in university and college degree programs in the U.S., Canada, and the UK. In addition, the company has a recruiting relationship with the regional campuses of Miami University of Ohio, where it maintains residential facilities, a full-service cafeteria, recreational facilities, shuttle buses, and an office for the regional campuses that provides study abroad and post-study services for its students; these facilities are not owned, maintained, operated or are part of Miami University. Company operated in three primary reportable segments foreign language education (QHI), foreign language education (RIL) and the professional training programs.
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.